Field & Main Bank - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,004 filers reported holding BAXTER INTL INC in Q3 2022. The put-call ratio across all filers is 1.55 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Field & Main Bank ownership history of BAXTER INTL INC
ValueSharesWeighting
Q2 2024$33,450
-39.8%
1,000
-23.1%
0.01%
-40.9%
Q1 2024$55,549
+10.6%
1,3000.0%0.02%
+4.8%
Q4 2023$50,245
+2.4%
1,3000.0%0.02%
-8.7%
Q3 2023$49,049
-17.2%
1,3000.0%0.02%
-30.3%
Q2 2023$59,228
-43.3%
1,300
-49.5%
0.03%
-46.8%
Q1 2023$104,442
-20.4%
2,5750.0%0.06%
-27.1%
Q4 2022$131,246
-25.0%
2,575
-20.8%
0.08%
-28.0%
Q3 2022$175,000
-27.4%
3,250
-13.3%
0.12%
-23.9%
Q2 2022$241,000
-7.3%
3,750
+11.9%
0.16%
-1.3%
Q1 2022$260,000
-17.5%
3,350
-8.7%
0.16%
-13.7%
Q4 2021$315,000
+6.8%
3,6700.0%0.18%
-6.2%
Q3 2021$295,000
-10.1%
3,670
-9.9%
0.19%
-7.6%
Q2 2021$328,000
+5.8%
4,075
+10.9%
0.21%
-5.4%
Q1 2021$310,000
+9.5%
3,675
+4.3%
0.22%
+5.2%
Q4 2020$283,000
+4.4%
3,525
+4.4%
0.21%
+1.0%
Q3 2020$271,000
-7.5%
3,375
-0.7%
0.21%
-16.4%
Q2 2020$293,000
-7.9%
3,400
-10.5%
0.25%
-5.3%
Q4 2019$318,000
-4.2%
3,8000.0%0.26%
-11.7%
Q3 2019$332,000
+6.8%
3,8000.0%0.30%
+4.9%
Q2 2019$311,000
+0.6%
3,8000.0%0.28%
-2.4%
Q1 2019$309,000
-2.2%
3,800
-7.3%
0.29%
+3.5%
Q3 2018$316,000
+6.4%
4,1000.0%0.28%
+4.4%
Q2 2018$297,000
+11.2%
4,1000.0%0.27%
+3.8%
Q1 2018$267,000
+0.8%
4,1000.0%0.26%
+2.4%
Q4 2017$265,0004,1000.25%
Other shareholders
BAXTER INTL INC shareholders Q3 2022
NameSharesValueWeighting ↓
Third Point 36,000,000$2,658,240,00018.52%
SECTOR GAMMA AS 721,058$53,243,0008.85%
SUVRETTA CAPITAL MANAGEMENT, LLC 2,747,061$202,843,0005.38%
Veritas Asset Management LLP 8,852,005$653,632,0005.36%
Knowledge Leaders Capital, LLC 79,384$5,862,0004.39%
HealthCor Management, L.P. 1,800,000$132,912,0004.22%
Progressive Investment Management Corp 79,282$5,854,0003.78%
13D Management LLC 200,318$14,791,0003.77%
ARGENT CAPITAL MANAGEMENT LLC 1,288,236$95,123,0003.42%
Chiron Investment Management, LLC 612,787$45,248,0003.12%
View complete list of BAXTER INTL INC shareholders